Vicarious Surgical Inc.

NYSE:RBOT Stok Raporu

Piyasa değeri: US$47.7m

Vicarious Surgical Gelecekteki Büyüme

Future kriter kontrolleri 0/6

Vicarious Surgical's earnings are forecast to decline at 3.8% per annum while its annual revenue is expected to grow at 66.3% per year. EPS is expected to grow by 32.8% per annum. Return on equity is forecast to be -143.4% in 3 years.

Anahtar bilgiler

-3.8%

Kazanç büyüme oranı

32.8%

EPS büyüme oranı

Medical Equipment kazanç büyümesi17.4%
Gelir büyüme oranı66.3%
Gelecekteki özkaynak getirisi-143.4%
Analist kapsamı

Low

Son güncelleme13 Aug 2024

Gelecekteki son büyüme güncellemeleri

Recent updates

Here's Why Vicarious Surgical (NYSE:RBOT) Must Use Its Cash Wisely

Aug 16
Here's Why Vicarious Surgical (NYSE:RBOT) Must Use Its Cash Wisely

Is Vicarious Surgical (NYSE:RBOT) In A Good Position To Invest In Growth?

Mar 05
Is Vicarious Surgical (NYSE:RBOT) In A Good Position To Invest In Growth?

Is Vicarious Surgical (NYSE:RBOT) In A Good Position To Invest In Growth?

Nov 24
Is Vicarious Surgical (NYSE:RBOT) In A Good Position To Invest In Growth?

Vicarious Surgical: Huge Potential But Low Margin Of Safety To Commercialization

Aug 24

Here's Why We're Watching Vicarious Surgical's (NYSE:RBOT) Cash Burn Situation

Jul 18
Here's Why We're Watching Vicarious Surgical's (NYSE:RBOT) Cash Burn Situation

Vicarious Surgical: Cash Burn Adds To Downside Risk

May 26

Vicarious Surgical Non-GAAP EPS of -$0.16 beats by $0.02

Feb 13

Vicarious Surgical Non-GAAP EPS of -$0.18 misses by $0.03

Nov 07

Vicarious Surgical Non-GAAP EPS of -$0.16 misses by $0.02

Aug 08

Vectoring In On Vicarious Surgical Inc.

Jun 23

Vicarious Surgical: Developing Minimally Invasive VR Surgical System

Nov 29

Kazanç ve Gelir Büyüme Tahminleri

NYSE:RBOT - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (USD Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
12/31/2026N/A-77N/AN/A3
12/31/2025N/A-74N/AN/A3
12/31/2024N/A-64N/AN/A3
6/30/2024N/A-61-55-54N/A
3/31/2024N/A-61-60-58N/A
12/31/2023N/A-71-64-62N/A
9/30/2023N/A-69-71-69N/A
6/30/2023N/A-78-68-66N/A
3/31/2023N/A-64-69-65N/A
12/31/2022N/A5-67-61N/A
9/30/2022N/A38-58-53N/A
6/30/2022N/A18-57-52N/A
3/31/2022N/A13-47-44N/A
12/31/2021N/A-35-35-33N/A
9/30/2021N/A-61-28-27N/A
6/30/2021N/A-19-17-16N/A
3/31/2021N/A-15-14-14N/A
12/31/2020N/A-13-12-12N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: RBOT is forecast to remain unprofitable over the next 3 years.

Kazançlar ve Piyasa: RBOT is forecast to remain unprofitable over the next 3 years.

Yüksek Büyüme Kazançları: RBOT is forecast to remain unprofitable over the next 3 years.

Gelir ve Pazar: RBOT is forecast to have no revenue next year.

Yüksek Büyüme Geliri: RBOT is forecast to have no revenue next year.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: RBOT is forecast to be unprofitable in 3 years.

Büyüyen şirketleri keşfedin

7D

1Y

7D

1Y

7D

1Y